RYNEX PSE (EDWARDS PHARMACEUTICALS, INC.)


Welcome to the PulseAid listing for the RYNEX PSE drug offered from EDWARDS PHARMACEUTICALS, INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: EDWARDS PHARMACEUTICALS, INC.
NON-PROPRIETARY NAME: BROMPHENIRAMINE MALEATE and PSEUDOEPHEDRINE HYDROCHLORIDE
SUBSTANCE NAME: BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2011-03-07
END MARKETING DATE: 0000-00-00


RYNEX PSE HUMAN OTC DRUG Details:

Item DescriptionRYNEX PSE from EDWARDS PHARMACEUTICALS, INC.
LABELER NAME: EDWARDS PHARMACEUTICALS, INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 1; 15(mg/5mL; mg/5mL)
START MARKETING DATE: 2011-03-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0485-0206_7a2f6dd4-7d1d-4058-a2f0-126327eb557f
PRODUCT NDC: 0485-0206
APPLICATION NUMBER: part341

Other BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ECR PharmaceuticalsLodrane D
EDWARDS PHARMACEUTICALS, INC.RYNEX PE
Preferred Pharmaceuticals, IncQ-Tapp
Silarx Pharmaceuticals, IncBrotapp